সিজোডন এমডি এ আছে Risperidone। সিজোডন এমডি এর কাজঃ

সিজোডন এমডি tablet is indicated for the treatment of acute and chronic schizophrenic psychoses, and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted affect, emotional and social withdrawal, poverty of speech) are prominent. সিজোডন এমডি also alleviate affective symptoms (such as depression, guilt feelings, anxiety) associated with schizophrenia. সিজোডন এমডি is also effective inmaintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. সিজোডন এমডি is in dicated for the treatment of mania in bipolar disorder.

Ads
Sizodon MD Mouth Dissolving Tablet 4 mg in bangla
ব্র্যান্ড নাম সিজোডন এমডি
জেনেরিকঃ Risperidone
পরিমাপঃ 4 mg
ধরণঃ Mouth Dissolving Tablet
চিকিৎসাগত শ্রেণিঃ Atypical neuroleptic drugs
উৎপাদনকারীঃ Sun Pharmaceutical (Bangladesh) Limited
দামঃ 0.00
সর্বশেষ সম্পাদনাঃ 2020-11-20 18:15:00
পরিচিতি

সিজোডন এমডি is a selective monoaminergic antagonist having a high affinity for serotoninergic 5-HT2 and dopaminergic D2 receptors. সিজোডন এমডি binds also to alpha1 adrenergic receptors and with lower affinity, to H1 histamine and alpha2 adrenergic receptors. সিজোডন এমডি has no affinity for cholinergic receptors. সিজোডন এমডি, as a potent D2 antagonist, improves the positive symptoms of schizophrenia but causes less depression of motor activity. Balanced central serotonin and dopamine antagonism may reduce extrapyramidal side effect liability and extend the therapeutic activity to the negative and affective symptoms of schizophrenia.

খাওয়ার নিয়ম

সিজোডন এমডি এ আছে Risperidone 4 mg। সিজোডন এমডি খাওয়ার নিয়ম নিম্নরূপঃ

Psychoses: 2 mg in 1-2 divided doses on 1st day then 4 mg in 1-2 divided doses on second day (Slower titration appropriate in some patients); usual dose range 4-6 mg daily; doses above 10 mg daily only if benefit considered to outweigh risk (max. 16 mg daily). Elderly (or in hepatic or renal impairment) initially 1 mg daily in two divided doses increased in steps of 1-2 mg twice daily. Child under 15 years not recommended.

Mania: Initially 2 mg once daily increased if necessary in step of 1 mg daily; usual dose range 1-6 mg daily; Elderly (or in hepatic or renal impairment) initially 1 mg daily in two divided doses increased in steps of 1-2 mg twice daily.

Schizophrenia: সিজোডন এমডি should be generally administered at 1 mg BID initially, with increases in increments of 1 mg BID on the second and third day, as tolerated, to a target dose of 3 mg BID by the third day. Further dosage adjustments, if indicated, should generally occur at intervals of not less than 1 week. When dosage adjustments are necessary, small dose increments or decrements of 1-2 mg are recommended.

 

পার্শ্বপ্রতিক্রিয়া

Insomnia, agitation, anxiety, headache, less commonly drowsiness, impaired concentration, fatigue, blurred vision, constipation, nausea and vomiting, dyspepsia, abdominal pain, hyperprolactinaemia, urine incontinence, tachycardia, hypertension, edema, rash, rhinitis, cerebrovascular accident, neurtropenia and thrombocytopenia have been reported.

Ads
সতর্কতা

Special precaution should be taken in case of preexisting cardiovascular diseases, discontinue use if signs and symptoms of tardive dyskinesia occur, renal and hepatic impairment, elderly epilepsy, Parkinson's disease and in pregnancy.

প্রতিক্রিয়া

সিজোডন এমডি May antagonize the effects of levodopa and dopamine agonists. Chronic administration with Carbamazepine reduces plasma clearance of সিজোডন এমডি. Chronic administration with Clozapine may decrease the clearance of সিজোডন এমডি. সিজোডন এমডি may enhance the effects of certain antihypertensives.

গর্ভকালীন কিংবা দুগ্ধদানকালীন অবস্থায় ব্যবহার

Pregnancy: Although, in experimental animals, সিজোডন এমডি did not show direct reproductive toxicity, some indirect, prolactin- and CNS-mediated effects were observed, No teratogenicity effect of সিজোডন এমডি was noted in any study. The safety of সিজোডন এমডি for use during human pregnancy has not been established.

Lactation: In animal studies, সিজোডন এমডি and 9-hydroxyrisperidone are excreted in the milk. It has been demonstrated that সিজোডন এমডি and 9-hydroxyrisperidone are also excreted in human breast milk. Therefore, women receiving সিজোডন এমডি should not breast feed.

প্রতিনির্দেশনা

সিজোডন এমডি is contraindicated in patients with a known hypersensitivity to the product.

বিশেষ সতর্কতা

 

মাত্রাতিরিক্ত সেবনের প্রতিক্রিয়া

Drowsiness, sedation, tachycardia, hypotension, and extrapyramidal symptoms may occur. In case of severe extrapyramidal symptoms, anticholinergic medication should be administered. Close medical supervision and monitoring should continue until the patient recovers. There is no specific antidote to সিজোডন এমডি.

অন্যান্য ঔষধের সাথে প্রতিক্রিয়া

 

সংরক্ষণ

Store in a cool and dry place, protected from light.

সিজোডন এমডি Mouth Dissolving Tablet এর দাম 0.00

Ads